Latest Valuation News

Brightstar Resources outlines a bold growth strategy targeting over 200,000 ounces of annual gold production by 2029, leveraging its Western Australian assets and aggressive drilling programs. The company’s recent feasibility studies and acquisitions position it as a rising gold producer in the region.

Cauldron Energy’s latest drilling campaign at Manyingee South significantly extends uranium mineralisation, revealing a more complex palaeochannel system and setting the stage for a resource update in early 2026.

Kingston Resources has launched a new drilling campaign at its Mineral Hill Mine, deploying two rigs to target high-grade extensions and near-mine discoveries. Early assays from Long Panel rock chips show promising copper grades, underpinning the company’s growth ambitions.

Infini Resources Limited’s I88OA securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Unico Silver Limited has completed a $40 million share placement and launched a $5 million Share Purchase Plan for eligible shareholders at a discounted price of $0.55 per share.

Trek Metals has raised $1 million through a strategic placement to fast-track exploration at its Christmas Creek manganese project, with investor Andrew Reece committing $500,000 and joining the board.

Far East Gold has reported exceptional high-grade gold assay results from drillhole KSD024 at its Sua Prospect in Indonesia, confirming an extension of bonanza-grade mineralisation and reinforcing the potential for resource growth.

Monash IVF has decisively turned down a non-binding acquisition offer valuing its shares at $0.80, citing significant undervaluation and uncertain financing. The Board signals openness only to proposals that deliver compelling shareholder value.

Macquarie Asset Management has tabled a $5.20 per share cash offer to acquire Qube Holdings, valuing the logistics giant at approximately $11.6 billion. The Qube board has entered an exclusivity agreement and signals unanimous support, pending due diligence and regulatory approvals.

New data reveals that Thoroughbred racehorses free from oxidative stress are significantly more likely to win or place, spotlighting OxiDx’s patented biomarker test as a game-changer in equine performance and welfare.

Sunshine Metals Limited will lift its trading suspension on 24 November 2025 following a key Supreme Court ruling. Investors await details on the court outcome that triggered the suspension.

The Foreign Investment Review Board has formally objected to Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma, casting serious doubt on the deal’s future and prompting Mayne to explore alternative paths.